Clinical cancer research and the areas which hold its’ interest

Clinical cancer research is a medical journal which is peer-reviewed and it is based on oncology. It

includes therapy, diagnosis, prevention, molecular and cellular characterization of human cancer. It also

covers clinical generics, surgical oncology, pathology, and pediatric oncology, and radiation therapy,

hematological and medical oncology.

What it entails

Also included are the application of different disciplines of molecular, cell biology, and immunology

genetics in the integration of cancer in humans. The main areas of interest are the clinical trials which

aim at the evaluation of the new treatments available together with molecular and pharmacology

alterations to predict resistance and response.

The other priority of the research is animal and laboratory studies of different drugs and agents that are

molecule targeted with the hope of conducting clinical studies and trials of metastatic disease,

malignant phenotype progression, and oncogenesis targetable mechanism.

The journal issues and what they cover

The clinical research has been in publication since 1995. Many publications have been submitted by all

sorts of investigators who represent different disciplines like clinical and laboratory all over the world.

With this publication, translational and innovative clinical cancer studies have been published in order to

bridge clinic and laboratory. This is a journal that holds interest in the clinical trials that evaluate any

new treatment. This is especially when it comes accompanied by pharmacology research and molecular

alterations or even biomarkers which are able to predict resistance and response to treatment


Animal and laboratory studies of any molecule targeted agents and drugs that have the potential to

require clinical trials are a priority too. It also focuses on studies of metastatic disease, malignant

phenotype progression, and oncogenesis of targetable mechanisms.

Other interest areas include:

 Human tumors molecular characterization

 Radiation and radiobiology oncology

 Gene therapy

 Clinical and immunotherapy immunology

 Application of biostatistics and bioinformatics personalized medicine

 Pharmacogenomics and pharmacogenetics among other areas

Rosa JonesComment